764 related articles for article (PubMed ID: 24845462)
1. T cell-mediated immune response to respiratory coronaviruses.
Channappanavar R; Zhao J; Perlman S
Immunol Res; 2014 Aug; 59(1-3):118-28. PubMed ID: 24845462
[TBL] [Abstract][Full Text] [Related]
2. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection.
Channappanavar R; Fett C; Zhao J; Meyerholz DK; Perlman S
J Virol; 2014 Oct; 88(19):11034-44. PubMed ID: 25056892
[TBL] [Abstract][Full Text] [Related]
3. Lessons for COVID-19 Immunity from Other Coronavirus Infections.
Sariol A; Perlman S
Immunity; 2020 Aug; 53(2):248-263. PubMed ID: 32717182
[TBL] [Abstract][Full Text] [Related]
4. T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV.
Liu WJ; Zhao M; Liu K; Xu K; Wong G; Tan W; Gao GF
Antiviral Res; 2017 Jan; 137():82-92. PubMed ID: 27840203
[TBL] [Abstract][Full Text] [Related]
5. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates.
Regla-Nava JA; Nieto-Torres JL; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodríguez C; Perlman S; Enjuanes L; DeDiego ML
J Virol; 2015 Apr; 89(7):3870-87. PubMed ID: 25609816
[TBL] [Abstract][Full Text] [Related]
6. Airway Memory CD4(+) T Cells Mediate Protective Immunity against Emerging Respiratory Coronaviruses.
Zhao J; Zhao J; Mangalam AK; Channappanavar R; Fett C; Meyerholz DK; Agnihothram S; Baric RS; David CS; Perlman S
Immunity; 2016 Jun; 44(6):1379-91. PubMed ID: 27287409
[TBL] [Abstract][Full Text] [Related]
7. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses.
Huang J; Cao Y; Du J; Bu X; Ma R; Wu C
Vaccine; 2007 Sep; 25(39-40):6981-91. PubMed ID: 17709158
[TBL] [Abstract][Full Text] [Related]
8. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology.
Honda-Okubo Y; Barnard D; Ong CH; Peng BH; Tseng CT; Petrovsky N
J Virol; 2015 Mar; 89(6):2995-3007. PubMed ID: 25520500
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the potential impact of targeted vaccination strategies against severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) outbreaks in the healthcare setting.
Abdirizak F; Lewis R; Chowell G
Theor Biol Med Model; 2019 Oct; 16(1):16. PubMed ID: 31587665
[TBL] [Abstract][Full Text] [Related]
10. Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen.
Yang L; Peng H; Zhu Z; Li G; Huang Z; Zhao Z; Koup RA; Bailer RT; Wu C
J Gen Virol; 2007 Oct; 88(Pt 10):2740-2748. PubMed ID: 17872527
[TBL] [Abstract][Full Text] [Related]
11. Genome-Wide B Cell, CD4
Prakash S; Srivastava R; Coulon PG; Dhanushkodi NR; Chentoufi AA; Tifrea DF; Edwards RA; Figueroa CJ; Schubl SD; Hsieh L; Buchmeier MJ; Bouziane M; Nesburn AB; Kuppermann BD; BenMohamed L
J Immunol; 2021 Jun; 206(11):2566-2582. PubMed ID: 33911008
[TBL] [Abstract][Full Text] [Related]
12. Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals.
Chen H; Hou J; Jiang X; Ma S; Meng M; Wang B; Zhang M; Zhang M; Tang X; Zhang F; Wan T; Li N; Yu Y; Hu H; Yang R; He W; Wang X; Cao X
J Immunol; 2005 Jul; 175(1):591-8. PubMed ID: 15972696
[TBL] [Abstract][Full Text] [Related]
13. Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection.
Ng OW; Chia A; Tan AT; Jadi RS; Leong HN; Bertoletti A; Tan YJ
Vaccine; 2016 Apr; 34(17):2008-14. PubMed ID: 26954467
[TBL] [Abstract][Full Text] [Related]
14. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.
Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM
Front Immunol; 2020; 11():1979. PubMed ID: 32973803
[TBL] [Abstract][Full Text] [Related]
15. Complete protection against severe acute respiratory syndrome coronavirus-mediated lethal respiratory disease in aged mice by immunization with a mouse-adapted virus lacking E protein.
Fett C; DeDiego ML; Regla-Nava JA; Enjuanes L; Perlman S
J Virol; 2013 Jun; 87(12):6551-9. PubMed ID: 23576515
[TBL] [Abstract][Full Text] [Related]
16. Immunological map in COVID-19.
Li CH; Chiou HC; Lin MH; Kuo CH; Lin YC; Lin YC; Hung CH; Kuo CH
J Microbiol Immunol Infect; 2021 Aug; 54(4):547-556. PubMed ID: 34023234
[TBL] [Abstract][Full Text] [Related]
17. Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients.
Yang LT; Peng H; Zhu ZL; Li G; Huang ZT; Zhao ZX; Koup RA; Bailer RT; Wu CY
Clin Immunol; 2006 Aug; 120(2):171-8. PubMed ID: 16781892
[TBL] [Abstract][Full Text] [Related]
18. Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses.
Huang J; Ma R; Wu CY
Vaccine; 2006 Jun; 24(23):4905-13. PubMed ID: 16621188
[TBL] [Abstract][Full Text] [Related]
19. TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection.
Iwata-Yoshikawa N; Okamura T; Shimizu Y; Hasegawa H; Takeda M; Nagata N
J Virol; 2019 Mar; 93(6):. PubMed ID: 30626688
[TBL] [Abstract][Full Text] [Related]
20. Characterization of SARS-CoV-specific memory T cells from recovered individuals 4 years after infection.
Fan YY; Huang ZT; Li L; Wu MH; Yu T; Koup RA; Bailer RT; Wu CY
Arch Virol; 2009; 154(7):1093-9. PubMed ID: 19526193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
